Abstract:Family communication is the primary, initial means of educating the next, at-risk generation about hereditary cancer risk. In this study, in-depth parent narratives provided self-report of motivations, planning, satisfactions and regrets associated with sharing or not sharing maternal BRCA1/2 test results with young children and advice for parents considering disclosure and for genetic counselors. Interviews were conducted with 32 mothers tested for BRCA1/2 with children ages 8–21 years and 24 of their co-pare… Show more
“…Early findings suggested that among families with mothers undergoing BRCA1/2 testing, children with greater psychological stress had more frequent thoughts of becoming sick and greater worries about cancer (Tercyak, Peshkin, Streisand, & Lerman, 2001). More recent research demonstrates that outcomes for parents and children in this context are influenced by several factors, such as the strength of the parent-child relationship and how genetic risk information is conveyed (Patenaude et al, 2012). There remains a need for empirical research determining how decision-making and psychological distress surrounding family communication of BRCA1/2 test results drive children's well-being so that supportive interventions can be developed and deployed.…”
Objective.
To investigate the influence of dyadic parenting relationships on psychological distress among mothers tested for BRCA1/2 genetic mutations and their untested partners.
Methods.
Data were from a prospective study of mothers suspected to be at risk for hereditary breast/ovarian cancer who underwent genetic counseling and BRCA1/2 testing and their untested parenting partners (n =109 parenting dyads). Participants completed assessments before and 1-month following genetic testing. Structural equation modeling was used to examine relationships among mothers' and partners' psychological distress, decisional conflict surrounding communication of test results to their offspring, and the parent-child communication relationship. Psychological distress was measured using items modified from the Brief Symptom Inventory.
Results.
Among mothers, greater psychological distress (B = 0.29, p < .001) and poorer parent-child communication (B = −0.12, p < .01) at baseline predicted greater distress at follow-up. Among partners, greater distress at baseline predicted greater distress at follow-up (B = 0.67, p < .001). Mother and partner decisional conflict at baseline were equally associated with the other dyad member’s distress at follow-up (B's = 1.17, p < .01), but not their own distress.
Conclusions.
Our findings indicate conflicted decision-making over family communication of hereditary breast/ovarian cancer genetic test results for one member of a parenting dyad adversely affects the other dyad member’s psychological well-being. Interventions to improve outcomes for mothers who may be at-risk for hereditary breast and ovarian cancer and undergoing BRCA1/2 genetic testing should attend to both mothers' and their partners' preferences regarding family communication about hereditary cancer risk.
“…Early findings suggested that among families with mothers undergoing BRCA1/2 testing, children with greater psychological stress had more frequent thoughts of becoming sick and greater worries about cancer (Tercyak, Peshkin, Streisand, & Lerman, 2001). More recent research demonstrates that outcomes for parents and children in this context are influenced by several factors, such as the strength of the parent-child relationship and how genetic risk information is conveyed (Patenaude et al, 2012). There remains a need for empirical research determining how decision-making and psychological distress surrounding family communication of BRCA1/2 test results drive children's well-being so that supportive interventions can be developed and deployed.…”
Objective.
To investigate the influence of dyadic parenting relationships on psychological distress among mothers tested for BRCA1/2 genetic mutations and their untested partners.
Methods.
Data were from a prospective study of mothers suspected to be at risk for hereditary breast/ovarian cancer who underwent genetic counseling and BRCA1/2 testing and their untested parenting partners (n =109 parenting dyads). Participants completed assessments before and 1-month following genetic testing. Structural equation modeling was used to examine relationships among mothers' and partners' psychological distress, decisional conflict surrounding communication of test results to their offspring, and the parent-child communication relationship. Psychological distress was measured using items modified from the Brief Symptom Inventory.
Results.
Among mothers, greater psychological distress (B = 0.29, p < .001) and poorer parent-child communication (B = −0.12, p < .01) at baseline predicted greater distress at follow-up. Among partners, greater distress at baseline predicted greater distress at follow-up (B = 0.67, p < .001). Mother and partner decisional conflict at baseline were equally associated with the other dyad member’s distress at follow-up (B's = 1.17, p < .01), but not their own distress.
Conclusions.
Our findings indicate conflicted decision-making over family communication of hereditary breast/ovarian cancer genetic test results for one member of a parenting dyad adversely affects the other dyad member’s psychological well-being. Interventions to improve outcomes for mothers who may be at-risk for hereditary breast and ovarian cancer and undergoing BRCA1/2 genetic testing should attend to both mothers' and their partners' preferences regarding family communication about hereditary cancer risk.
“…Parents may or may not convey information about risk of having a mutation accurately (Patenaude et al, 2013). Many parents are faced with the decision to tell children when a mother undergoes prophylactic surgery (Farkas Patenaude et al, 2012). The importance of honesty and Provides resources and support for women of Jewish ancestry who have a genetic predisposition for developing cancer • Phone support • Local support groups • Education and publications emphasizing that a mother is taking all steps to prevent future problems should not be underestimated.…”
Previvors are individuals who are survivors of a genetic predisposition for developing cancer. They often are confronted with difficult decisions about management of risks that might include aggressive screening and prophylactic surgery. Psychosocial challenges exist for the affected individual, their partners, and offspring. Oncology nurses need to be aware of the complex and special needs of this ever-growing population.
“…Although many women report pursing BRCA1/2 counseling and testing to learn about hereditary cancer risk information for the benefit of their family members (Tercyak et al 2002), patient decisions to disclose results to their kindred are often driven by anticipation of how they will react emotionally to learning their test result (Dorval et al 2000;Farkas Patenaude et al 2013). Therefore, greater attention to emotional forecasting of the outcomes of this decision-making process could allow for interventions to reduce negative anticipation among mothers.…”
Women tested for mutations in BRCA1/2 genes who have minor-aged children confront difficult decisions about if, when, and how to share information about hereditary cancer risk with their children. These choices are often seemingly influenced by how mothers anticipate the emotional burdens they and their children will experience in response to test results. Here, we investigate the association between maternal cognitions, pretest psychological well-being, and coping style with mothers' anticipated emotional reactions to learning that they are BRCA1/2 mutation carriers (N=205). In a linear regression model adjusted for maternal demographics, stronger tendencies to ruminate about information (B=.14, p=.03), greater psychological strain (B=.14, p<.001), and poorer appraisals of one's ability to cope with genetic test results conveying increased breast cancer risk information (B=−.25, p<.001) were significantly associated with anticipating more negative affect surrounding BRCA1/2 mutation identification in mothers. Our data contribute to the growing awareness of special concerns that mothers have about knowing their BRCA1/2 mutation status and highlight the need for more tailored patient education and counseling resources to improve outcomes among women at risk and their children.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.